高龄急性冠脉综合征的治疗进展

Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic （ASSENT）-3 and ASSENT-3 PLUS[J] . Peter R. Sinnaeve,Yao Huang,Kris Bogaerts,Alec Vahanian,Jennifer Adgey,Paul W. Armstrong,Lars Wallentin,Frans J. Van de Werf,Christopher B. Granger.American Heart Journal . 2006 (4)

Impact of the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22/Reversal of Atherosclerosis With Aggressive Lipid Lowering Trials on Trends in Intensive Versus Moderate Statin Therapy in Ontario, Canada[J] . Peter C. Austin,Muhammad M. Mamdani.Circulation . 2005 (9)

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivit?ts Trial （BASKET）[J] . Christoph Kaiser,Hans Peter Brunner-La Rocca,Peter T Buser,Piero O Bonetti,Stefan Osswald,André Linka,Alain Bernheim,Andreas Zutter,Michael Zellweger,Leticia Grize,Matthias E Pfisterer.The Lancet . 2005 (9489)

Correlation between the TIMI risk score and high-risk angiographic findings in non–ST-elevation acute coronary syndromes: Observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms （PRISM-PLUS） trial[J] . Jessica L. Mega,David A. Morrow,Marc S. Sabatine,Xue-Qiao Zhao,Steven M. Snapinn,Peter M. DiBattiste,C. Michael Gibson,Elliott M. Antman,Eugene Braunwald,Pierre Théroux.American Heart Journal . 2005 (5)

Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial[J] . The Lancet . 2005 (9497)

Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic （ASSENT）-3 and ASSENT-3 PLUS[J] . Peter R. Sinnaeve,Yao Huang,Kris Bogaerts,Alec Vahanian,Jennifer Adgey,Paul W. Armstrong,Lars Wallentin,Frans J. Van de Werf,Christopher B. Granger.American Heart Journal . 2006 (4)

Impact of the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22/Reversal of Atherosclerosis With Aggressive Lipid Lowering Trials on Trends in Intensive Versus Moderate Statin Therapy in Ontario, Canada[J] . Peter C. Austin,Muhammad M. Mamdani.Circulation . 2005 (9)

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivit?ts Trial （BASKET）[J] . Christoph Kaiser,Hans Peter Brunner-La Rocca,Peter T Buser,Piero O Bonetti,Stefan Osswald,André Linka,Alain Bernheim,Andreas Zutter,Michael Zellweger,Leticia Grize,Matthias E Pfisterer.The Lancet . 2005 (9489)

Correlation between the TIMI risk score and high-risk angiographic findings in non–ST-elevation acute coronary syndromes: Observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms （PRISM-PLUS） trial[J] . Jessica L. Mega,David A. Morrow,Marc S. Sabatine,Xue-Qiao Zhao,Steven M. Snapinn,Peter M. DiBattiste,C. Michael Gibson,Elliott M. Antman,Eugene Braunwald,Pierre Théroux.American Heart Journal . 2005 (5)

Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial[J] . The Lancet . 2005 (9497)